SCHEMBL296254

SCHEMBL296254

O=C(C=Cc1ccn(S(=O)(=O)c2ccc(-c3ccccn3)s2)c1)NO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP3 P08254 2/20 0.47
▸ MMP1 P03956 1/20 0.47
▸ MMP2 P08253 1/20 0.47
▸ MMP7 P09237 1/20 0.47
▸ HDAC1 Q13547 13/20 0.45
▸ HDAC6 Q9UBN7 9/20 0.45
▸ HDAC8 Q9BY41 10/20 0.45
▸ HDAC3 O15379 8/20 0.45
▸ HDAC4 P56524 7/20 0.44
▸ HDAC7 Q8WUI4 7/20 0.44
▸ HDAC2 Q92769 7/20 0.44
▸ HDAC10 Q969S8 7/20 0.44
▸ HDAC11 Q96DB2 7/20 0.44
▸ HDAC9 Q9UKV0 7/20 0.44
▸ HDAC5 Q9UQL6 7/20 0.44
▸ MMP8 P22894 2/20 0.42
▸ PFKFB3 Q16875 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ ABL1 P00519 1/20 0.40
▸ EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL296253 1.00 MMP3 (0.47) MMP3MMP1MMP2MMP7HDAC1
Hydrochloric Acid SCHEMBL4452524 0.99 HDAC1 (0.46) MMP3MMP1MMP2MMP7HDAC1
Hydrochloric Acid SCHEMBL4452530 0.99 HDAC1 (0.46) MMP3MMP1MMP2MMP7HDAC1
SCHEMBL296182 0.97 MMP3 (0.47) MMP3MMP1MMP2MMP7HDAC1
SCHEMBL296180 0.97 MMP3 (0.47) MMP3MMP1MMP2MMP7HDAC1
SCHEMBL296811 0.94 HDAC1 (0.46) MMP3MMP1MMP2MMP7HDAC1
SCHEMBL296809 0.94 HDAC1 (0.46) MMP3MMP1MMP2MMP7HDAC1
SCHEMBL297030 0.94 MMP3 (0.44) MMP3MMP1MMP2MMP7HDAC1
SCHEMBL297032 0.94 MMP3 (0.44) MMP3MMP1MMP2MMP7HDAC1
SCHEMBL297001 0.90 HDAC1 (0.44) MMP3MMP1MMP2MMP7HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725528-B1 SULPHONYLPYRROLES AS HDAC INHIBITORS 4SC AG (DE) 2013-05-29 — — EP claimed
EP-1928826-B1 SULPHONYLPYRROLE HYDROCHLORIDE SALTS AS HISTONE DEACETYLASES INHIBITORS 4SC AG (DE) 2013-04-24 — — EP claimed
US-20130079347-A1 NOVEL SULFONYLPYRROLES ALTANA PHARMA AG (DE) 2013-03-28 — — US claimed
US-8232297-B2 Sulphonylpyrroles as inhibitors of HDACs novel sulphonylpyrroles 4SC AG (DE) 2012-07-31 — — US claimed
EP-1928872-B1 NOVEL SULPHONYLPYRROLES AS INHIBITORS OF HDAC 4SC AG (DE) 2012-03-14 — — EP claimed
US-8067615-B2 Sulphonylpyrroles 4SC AG (DE) 2011-11-29 — — US claimed
US-20110166140-A1 NOVEL SULPHONYLPYRROLES MAIER THOMAS 2011-07-07 — — US claimed
US-20100261761-A1 Novel Sulfonylpyrroles MAIER THOMAS 2010-10-14 — — US claimed
US-20100261721-A1 Novel Sulphonylpyrroles MAIER THOMAS 2010-10-14 — — US claimed
US-20090297473-A1 Sulphonylpyrrole Hydrochloride Salts as Histone Deacetylases Inhibitors NYCOMED GMBH (DE) 2009-12-03 — — US claimed
US-20090263353-A1 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles NYCOMED GMBH (DE) 2009-10-22 — — US claimed
EP-1928872-A1 NOVEL SULPHONYLPYRROLES AS INHIBITORS OF HDAC S NOVEL SULPHONYLPYRROLES Nycomed GmbH (DE) 2008-06-11 — — EP claimed
EP-1928826-A1 SULPHONYLPYRROLE HYDROCHLORIDE SALTS AS HISTONE DEACETYLASES INHIBITORS Nycomed GmbH (DE) 2008-06-11 — — EP claimed
US-20070184979-A1 Novel sulfonylpyrroles ALTANA PHARMA AG (DE) 2007-08-09 — — US claimed
WO-2007039404-A1 NOVEL SULPHONYLPYRROLES AS INHIBITORS OF HDAC S NOVEL SULPHONYLPYRROLES NYCOMED GMBH (DE) 2007-04-12 — — WO claimed
WO-2007039403-A1 SULPHONYLPYRROLE HYDROCHLORIDE SALTS AS HISTONE DEACETYLASES INHIBITORS NYCOMED GMBH (DE) 2007-04-12 — — WO claimed
EP-1725528-A2 SULPHONYLPYRROLES AS HDAC INHIBITORS Altana Pharma AG (DE) 2006-11-29 — — EP claimed
WO-2005087724-A2 SULPHONYLPYRROLES AS HDAC INHIBITORS ALTANA PHARMA AG (DE) 2005-09-22 — — WO claimed
US-8969401-B2 Sulfonylpyrroles 4SC AG (DE) 2015-03-03 — — US disclosed
WO-2005087724-A2 SULPHONYLPYRROLES AS HDAC INHIBITORS ALTANA PHARMA AG (DE) 2005-09-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090263353-A1 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles HDAC1, HDAC3, HDAC2 MMP3 2718/4885MMP1 3639/4885MMP2 2844/4885
US-20070184979-A1 Novel sulfonylpyrroles HDAC1, HDAC4, HDAC3 MMP3 2776/4885MMP1 3636/4885MMP2 2958/4885
US-20110166140-A1 NOVEL SULPHONYLPYRROLES HDAC1, HDAC3, HDAC2 MMP3 3059/4885MMP1 3619/4885MMP2 2933/4885
US-20100261761-A1 Novel Sulfonylpyrroles HDAC3, HDAC1, HDAC2 MMP3 3398/4885MMP1 4030/4885MMP2 3013/4885
US-20100261721-A1 Novel Sulphonylpyrroles HDAC1, HDAC3, HDAC2 MMP3 3059/4885MMP1 3619/4885MMP2 2933/4885
US-20090297473-A1 Sulphonylpyrrole Hydrochloride Salts as Histone Deacetylases Inhibitors HDAC1, HDAC3, HDAC2 MMP3 1519/4885MMP1 2221/4885MMP2 1707/4885
US-20130079347-A1 NOVEL SULFONYLPYRROLES HDAC3, HDAC1, HDAC2 MMP3 3398/4885MMP1 4030/4885MMP2 3013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback